Prohibition Partners · Free weekly briefing
International Cannabis Weekly
The week’s global cannabis news, read through the analyst’s lens — one sentence per story, sourced.
373
7 regions29 stories14 countries
Top story
DEA cannabis rescheduling hearing delayed until 2025
Chief Administrative Law Judge (ALJ) has issued a preliminary order signalling that the information provided on those set to testify was insufficient and requesting additional details and potential availability for a formal hearing in January or February 2025.
USRegulationlink no longer available
- 01
Judge says New York's crackdown on unlicensed stores is unconstitutional
USRegulationlink no longer available
- 02
Pilot project in Frankfurt could see THC products sold legally
DEAdult-uselink no longer available
Europe
6 stories- European medical cannabis boom driven by telemedicine and regulatory reforms
EUMedicallink no longer available
- 118% surge in UK medical cannabis prescriptions but awareness among professionals lags
GBMedicallink no longer available
- Italian administrative court suspends decree classifying CBD as narcotic for third time
ITRegulationlink no longer available
- Oireachtas committee pushes decriminalisation of cannabis in Ireland
IEAdult-uselink no longer available
- UK backs proposition to raise THC limit in hemp to 0.3%
GBHemp & CBDlink no longer available
- Bedrocan expands into Denmark with high-CBD medical cannabis strain
DKMedicallink no longer available
United States
6 stories- New York legal cannabis market ready to hit its stride
USAdult-uselink no longer available
- DEA cannabis rescheduling hearing delayed until next year
USRegulationlink no longer available
- Majority of U.S. cannabis users favour Kamala Harris over Trump
USEvents & Industrylink no longer available
- Kansas poll finds majority favour medical and adult-use cannabis legalisation
USRegulationlink no longer available
- South Dakota medical cannabis industry calls for rule changes
USMedicallink no longer available
- Adults over 21 can purchase cannabis with delivery in Arizona
USAdult-uselink no longer available
Canada
6 stories- Canadian cannabis market shows stagnation with almost zero growth in 2024
CABusiness & Investmentlink no longer available
- Ontario steps up crackdown on illicit cannabis with CA$31 million investment
CARegulationlink no longer available
- New Brunswick sees rise in popularity of convenient cannabis products
CAAdult-uselink no longer available
- GCAC forms collaboration to deliver cannabis care for Canadian veterans
CAMedicallink no longer available
- Decibel acquires AgMedica and announces positive Q3 2024 outlook
CABusiness & Investmentlink no longer available
- Ayurcann posts record gross revenue of CA$45 million for fiscal 2024
CABusiness & Investmentlink no longer available
LATAM & Caribbean
2 stories- Costa Rica grants 57 hemp production licences
CRRegulationlink no longer available
- Brazil's Cannabis Federation criticises Sindusfarma's import restriction proposal
BRRegulationlink no longer available
Africa & Middle East
2 stories- Morocco's cannabis industry grows as green gold sparks economic opportunities
MABusiness & Investmentlink no longer available
- South African company Nexus launches major cannabis processing and export project
ZABusiness & Investmentlink no longer available
APAC
1 story- Thai cabinet approves bill to clarify commercial cannabis and hemp regulations
THRegulationlink no longer available
Oceania
3 stories- Australian companies frustrated with reliance on cannabis imports from Canada
AUBusiness & Investmentlink no longer available
- New Zealand's Puro partners with Māori group on medical cannabis production
NZMedicallink no longer available
- Legalise Cannabis Party achieves strong result in Queensland state election
AUEvents & Industrylink no longer available
Never miss an issue
International Cannabis Weekly in your inbox every week — the global developments that move the market, with the data behind them.
From the research library
Global Medical Cannabis Market Review
14 key international markets, 2025–2030. Sizing, forecasts and regulatory outlook.
From £1,265
View report